Intravenous Neostigmine for Postoperative Acute Colonic Pseudo-Obstruction

Objective: To review the literature on the safety and effectiveness of neostigmine for the treatment of postoperative acute colonic pseudo-obstruction. Data Sources: The MEDLINE/PubMed, EMBASE, and Cochrane databases from November 1969 to November 2011 were queried for articles published in English, using the search terms neostigmine, acute colonic pseudo-obstruction, postoperative, surgery, and Ogilvie syndrome. Study Selection and Data Extraction: All relevant original studies, meta-analyses, systematic reviews, guidelines, and review articles were assessed for inclusion. References from pertinent articles were examined for additional content not found during the initial search. Data Synthesis: Neostigmine may provide an effective treatment option for postoperative acute colonic pseudo-obstruction (ACPO) after conservative treatment measures have failed. One randomized controlled trial, 8 prospective and 3 retrospective observational studies, and 9 case reports evaluated neostigmine for ACPO. Included studies were limited by small sample sizes and heterogeneous populations not focused on postoperative patients, use of adjuvant agents, and lack of a consistent neostigmine regimen. Conclusions: Neostigmine may be a safe and effective treatment option for postoperative ACPO; however, current data do not support its use as a first-line intervention. Prospective and retrospective studies have demonstrated improvement in clinical symptoms, reduction in time to resolution, and reduction of recurrence for patients who failed conservative management. Prospective clinical trial data that evaluate early neostigmine versus conservative management are critically needed to determine neostigmine's role as a first-line therapy for ACPO.

[1]  L. White,et al.  Continuous neostigmine infusion versus bolus neostigmine in refractory Ogilvie syndrome. , 2011, The American journal of emergency medicine.

[2]  H. Ozkurt,et al.  Acute colonic pseudo-obstruction (Ogilvie's syndrome): radiologic diagnosis and medical treatment with neostigmine. Report of 4 cases. , 2009, The American journal of emergency medicine.

[3]  T. Bourgeron,et al.  Acute colonic pseudo‐obstruction , 1992, The British journal of surgery.

[4]  R. McNamara,et al.  Acute colonic pseudo-obstruction: rapid correction with neostigmine in the emergency department. , 2008, The Journal of emergency medicine.

[5]  S. Castle,et al.  POSTOPERATIVE DELIRIUM AND OGILVIE'S SYNDROME RESOLVING WITH NEOSTIGMINE , 2006, Journal of the American Geriatrics Society.

[6]  R. Mehta,et al.  Factors predicting successful outcome following neostigmine therapy in acute colonic pseudo‐obstruction: A prospective study , 2006, Journal of gastroenterology and hepatology.

[7]  M. Kimmey,et al.  Systematic review: acute colonic pseudo‐obstruction , 2005, Alimentary pharmacology & therapeutics.

[8]  A. Fazel,et al.  New solutions to an old problem: acute colonic pseudo-obstruction. , 2005, Journal of clinical gastroenterology.

[9]  A. Fu.  Neostigmine: an alternative treatment for constipation. , 2005, Dynamics.

[10]  H. Coşkun,et al.  Neostigmine for the Treatment of Acute Colonic Pseudo-Obstruction (Ogilvie's Syndrome) in a Patient on CAPD , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[11]  M. Borgaonkar,et al.  CASE REPORT: Acute on Chronic Intestinal Pseudoobstruction Responds to Neostigmine , 2000, Digestive Diseases and Sciences.

[12]  X. Calvet,et al.  Repeated Neostigmine Dosage as Palliative Treatment for Chronic Colonic Pseudo-Obstruction in a Patient With Autonomic Paraneoplastic Neuropathy , 2003, American Journal of Gastroenterology.

[13]  D. Faigel,et al.  Acute colonic pseudo-obstruction. , 2002, Gastrointestinal endoscopy.

[14]  T. Baron,et al.  Assessment of predictors of response to neostigmine for acute colonic pseudo-obstruction , 2002, American Journal of Gastroenterology.

[15]  D. Benson,et al.  The use of neostigmine to treat postoperative ileus in orthopedic spinal patients. , 2001, Journal of spinal disorders.

[16]  A. Tafuri,et al.  Ogilvie's syndrome in acute myeloid leukemia: pharmacological approach with neostigmine , 2001, Annals of Hematology.

[17]  C. Schermer,et al.  Retrospective Study of Neostigmine for the Treatment of Acute Colonic Pseudo-Obstruction , 2001, The American surgeon.

[18]  N. Hyman,et al.  Neostigmine: Safe and effective treatment for acute colonic pseudo‐obstruction , 2000, Diseases of the colon and rectum.

[19]  H. Paran,et al.  Treatment of acute colonic pseudo-obstruction with neostigmine. , 2000, Journal of the American College of Surgeons.

[20]  M. Kimmey,et al.  Neostigmine for the treatment of acute colonic pseudo-obstruction. , 1998, The New England journal of medicine.

[21]  F. Turégano-Fuentes,et al.  Early resolution of Ogilvie's syndrome with intravenous neostigmine , 1997, Diseases of the colon and rectum.

[22]  M. Wheeler,et al.  Ogilvie's syndrome: A new approach to an old problem , 1995, Diseases of the colon and rectum.

[23]  M. Wheeler,et al.  Parasympathomimetic decompression of acute colonic pseudo-obstruction , 1993, The Lancet.

[24]  C. Griffiths,et al.  Acute colonic pseudo-obstruction: a pharmacological approach. , 1992, Annals of the Royal College of Surgeons of England.

[25]  S. Dorudi,et al.  Acute colonic pseudo‐obstruction , 1992, The British journal of surgery.

[26]  V. Vanek,et al.  Acute pseudo-obstruction of the colon (Ogilvie's syndrome) , 1986, Diseases of the colon and rectum.

[27]  Catchpole Bn.  Ileus: use of sympathetic blocking agents in its treatment. , 1969 .

[28]  B. Catchpole.  Ileus: use of sympathetic blocking agents in its treatment. , 1969, Surgery.